The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...

Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Diamond Drugs Inc., the primary sponsor of the Angels’ Wings Program in partnership with the Indiana County Community Action ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Corporate securities filings this year are littered with glimpses into new businesses risks, from costs related to President ...

Declining sugar consumption among people taking GLP-1 drugs to combat diabetes and obesity and the impact of President’s ...

When those of us of a certain age were growing up we were inundated with anti-drug messages. From then-First Lady Nancy ...